Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (46)
Cong Zhao, Li Tong, Bin Liu, Fei Qi, Zhiyun Zhang, Yi Guo, Yanxia Liu, Ying Wang, Lina Zhang, Baohua Lu, Baolan Li & Tongmei Zhang. (2023) Plasma hepatocyte growth factor as a noninvasive biomarker in small cell lung cancer. BMC Cancer 23:1.
Crossref
Crossref
Tessa Buckle, Maarten van Alphen, Matthias N. van Oosterom, Florian van Beurden, Nina Heimburger, Jaqueline E. van der Wal, Michiel van den Brekel, Fijs W. B. van Leeuwen & Baris Karakullukcu. (2021) Translation of c-Met Targeted Image-Guided Surgery Solutions in Oral Cavity Cancer—Initial Proof of Concept Data. Cancers 13:11, pages 2674.
Crossref
Crossref
Chong Zhang, Xida Zhao, Weidong Du, Jing Shen, Siqi Li, Zijia Li, Zengxu Wang & Fayu Liu. (2020) Ran promotes the proliferation and migration ability of head and neck squamous cell carcinoma cells. Pathology - Research and Practice 216:6, pages 152951.
Crossref
Crossref
Martin Khan, Sami S. Khaznadar, Johannes Routila, Sami Ventelä, Elke Schmid, Bastian Gebhart, Eva T. Becker, Helge G. Roider, Merja Perala, Arndt A. Schmitz, Thomas Krahn & Oliver Ahsen. (2020) Hepatocyte Growth Factor Receptor overexpression predicts reduced survival but its targeting is not effective in unselected HNSCC patients. Head & Neck 42:4, pages 625-635.
Crossref
Crossref
Misaki Yokokawa, Kei‐ichi Morita, Yu Oikawa, Kou Kayamori, Kei Sakamoto, Tohru Ikeda & Hiroyuki Harada. (2019) Co‐expression of EGFR and MET has a synergistic effect on the prognosis of patients with oral squamous cell carcinoma. Journal of Oral Pathology & Medicine 49:3, pages 235-242.
Crossref
Crossref
David M. Francis, Gopika Senthilkumar, Huaising C. Ko & Andrew M. Baschnagel. 2020. Improving the Therapeutic Ratio in Head and Neck Cancer. Improving the Therapeutic Ratio in Head and Neck Cancer
263
280
.
Lei Li, Zhijun Sun, Xin Huang, Xiao Li, Lihua Sun, Lei Zhang, Xiaodan Zhang, Longwei Ye, Jie Yuan, Limin Mao & Guolin Li. (2019) Role of c‐Met expression on prognosis of head and neck cancer: A literature review and meta‐analysis. Head & Neck 41:6, pages 1999-2006.
Crossref
Crossref
Vit Vsiansky, Jaromir Gumulec, Martina Raudenska & Michal Masarik. (2018) Prognostic role of c-Met in head and neck squamous cell cancer tissues: a meta-analysis. Scientific Reports 8:1.
Crossref
Crossref
Jung Han Kim, Bum Jun Kim & Hyeong Su Kim. (2017) Clinicopathological impacts of high c-Met expression in head and neck squamous cell carcinoma: a meta-analysis and review. Oncotarget 8:68, pages 113120-113128.
Crossref
Crossref
Mei Jiang, Hui Zhang, He Xiao, Zhimin Zhang, Dan Que, Jia Luo, Jian Li, Bijing Mao, Yuanyuan Chen, Meilin Lan, Ge Wang & Hualiang Xiao. (2017) High expression of c‑Met and EGFR is associated with poor survival of patients with glottic laryngeal squamous cell carcinoma. Oncology Letters.
Crossref
Crossref
Petr Szturz, Marie Budíková, Jan B. Vermorken, Ivana Horová, Břetislav Gál, Eric Raymond, Armand de Gramont & Sandrine Faivre. (2017) Prognostic value of c-MET in head and neck cancer: A systematic review and meta-analysis of aggregate data. Oral Oncology 74, pages 68-76.
Crossref
Crossref
Natalie Rothenberger & Laura Stabile. (2017) Hepatocyte Growth Factor/c-Met Signaling in Head and Neck Cancer and Implications for Treatment. Cancers 9:12, pages 39.
Crossref
Crossref
P. Szturz, E. Raymond, C. Abitbol, S. Albert, A. de Gramont & S. Faivre. (2017) Understanding c-MET signalling in squamous cell carcinoma of the head & neck. Critical Reviews in Oncology/Hematology 111, pages 39-51.
Crossref
Crossref
Shuang Li, Haiyang Zhang, Xinyi Wang, Yanjun Qu, Jingjing Duan, Rui Liu, Ting Deng, Tao Ning, Le Zhang, Ming Bai, Likun Zhou, Xia Wang, Shaohua Ge, Guoguang Ying & Yi Ba. (2016) Direct targeting of HGF by miR-16 regulates proliferation and migration in gastric cancer. Tumor Biology 37:11, pages 15175-15183.
Crossref
Crossref
Blake M. Warner & Jennifer Grandis. 2016. Targeting Oral Cancer. Targeting Oral Cancer
163
209
.
Insoon Chang, Aasia O. Rehman & Cun-Yu Wang. 2016. Targeting Oral Cancer. Targeting Oral Cancer
71
99
.
Pedro H. Isaacsson Velho, Gilberto CastroJr.Jr. & Christine H. Chung. (2015) Novel Targeted Agents in Head and Neck Squamous Cell Carcinoma. Hematology/Oncology Clinics of North America 29:6, pages 993-1009.
Crossref
Crossref
NAN ZHANG, FUBO XIE, WEI GAO, SHUWEN YU, LIYUN QIU, WENLI LIN, YUPING SUN & TANGHONG JIA. (2015) Expression of hepatocyte growth factor and c-Met in non-small-cell lung cancer and association with lymphangiogenesis. Molecular Medicine Reports 11:4, pages 2797-2804.
Crossref
Crossref
Ken Akashi, Yasuhiro Ebihara, Go Omura, Yuki Saito, Masafumi Yoshida, Mizuo Ando, Takahiro Asakage, Tatsuya Yamasoba & Yoshinori Murakami. (2015) Frequent Copy Gain of the <i>MET</i> Gene in Hypopharyngeal and Laryngeal Cancer in the Japanese Population. Journal of Cancer Therapy 06:12, pages 1093-1102.
Crossref
Crossref
Lluís Nisa, Daniel Matthias Aebersold, Roland Giger, Yitzhak Zimmer & Michaela Medová. (2014) Biological, diagnostic and therapeutic relevance of the MET receptor signaling in head and neck cancer. Pharmacology & Therapeutics 143:3, pages 337-349.
Crossref
Crossref
Yohei Ozawa, Yasuhiro Nakamura, Fumiyoshi Fujishima, Saulo J. A. Felizola, Kenichiro Takeda, Ken Ito, Hiroshi Okamoto, Takashi Kamei, Go Miyata, Noriaki Ohuchi & Hironobu Sasano. (2014) Cytoplasmic hepatocyte growth factor immunoreactivity predicting lymph node metastasis in esophageal squamous cell carcinoma. Esophagus 11:4, pages 223-230.
Crossref
Crossref
Mi Jung Kwon, Dong Hoon Kim, Hye-Rim Park, Hyung Sik Shin, Ji Hyun Kwon, Dong Jin Lee, Jin Hwan Kim, Seong Jin Cho & Eun Sook Nam. (2014) Frequent hepatocyte growth factor overexpression and low frequency of c-Met gene amplification in human papillomavirus–negative tonsillar squamous cell carcinoma and their prognostic significances. Human Pathology 45:7, pages 1327-1338.
Crossref
Crossref
Daniel W Bowles, Jessica D McDermott & Antonio Jimeno. (2014) Novel treatments for head and neck squamous cell carcinoma: preclinical identification and clinical investigation. Future Oncology 10:6, pages 1065-1080.
Crossref
Crossref
B-S Lee, S Kang, K-A Kim, Y-J Song, K H Cheong, H-Y Cha & C-H Kim. (2014) Met degradation by SAIT301, a Met monoclonal antibody, reduces the invasion and migration of nasopharyngeal cancer cells via inhibition of EGR-1 expression. Cell Death & Disease 5:4, pages e1159-e1159.
Crossref
Crossref
Elaine Mai, Zhong Zheng, Youjun Chen, Jing Peng, Christophe Severin, Ellen Filvaroff, Mally Romero, William Mallet, Surinder Kaur, Thomas Gelzleichter, Ihsan Nijem, Mark Merchant & Judy C. Young. (2014) Nonclinical Evaluation of the Serum Pharmacodynamic Biomarkers HGF and Shed MET following Dosing with the Anti-MET Monovalent Monoclonal Antibody Onartuzumab. Molecular Cancer Therapeutics 13:2, pages 540-552.
Crossref
Crossref
Ludovic Lacroix, Sophie F. Post, Alexander Valent, Antoine E. Melkane, Philippe Vielh, Coumaran Egile, Christelle Castell, Christelle Larois, Sandrine Micallef, Patrick Saulnier, Hélène Goulaouic, Anne-Marie Lefebvre & Stéphane Temam. (2014) MET Genetic Abnormalities Unreliable for Patient Selection for Therapeutic Intervention in Oropharyngeal Squamous Cell Carcinoma. PLoS ONE 9:1, pages e84319.
Crossref
Crossref
Yiru Xu & Gary Fisher. (2013) Role of Met Axis in Head and Neck Cancer. Cancers 5:4, pages 1601-1618.
Crossref
Crossref
Yiru Xu, Jin Zhou, Thomas E Carey, Jonathan B McHugh, John J Voorhees & Gary J Fisher. (2012) Receptor-type Protein Tyrosine Phosphatase β Regulates Met Phosphorylation and Function in Head and Neck Squamous Cell Carcinoma. Neoplasia 14:11, pages 1015-1022.
Crossref
Crossref
Young Chang Lim, Jae Ho Han, Hyun Jung Kang, Young Sook Kim, Bum Hei Lee, Eun Chang Choi & Chul-Ho Kim. (2012) Overexpression of c-Met promotes invasion and metastasis of small oral tongue carcinoma. Oral Oncology 48:11, pages 1114-1119.
Crossref
Crossref
Ji-Young ChoeJi Yun YunSoo-Jeong NamJi Eun Kim. (2012) Expression of c-Met Is Different along the Location and Associated with Lymph Node Metastasis of Head and Neck Carcinoma. Korean Journal of Pathology 46:6, pages 515.
Crossref
Crossref
Dan Zhao, Si-Hua Wang, Yang Feng, Cheng-Ge Hua, Jun Zhao & Xiu-Fa Tang. (2011) Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker. Human Pathology 42:10, pages 1514-1523.
Crossref
Crossref
Iwona Gisterek, Ewelina Lata, Agnieszka Halon, Rafal Matkowski, Jolanta Szelachowska, Przemyslaw Biecek & Jan Kornafel. (2011) Prognostic role of c-met expression in breast cancer patients. Reports of Practical Oncology & Radiotherapy 16:5, pages 173-177.
Crossref
Crossref
Patrick Chi-pan Lau & Anthony Tak-cheung Chan. (2011) Novel therapeutic target for head and neck squamous cell carcinoma. Anti-Cancer Drugs 22:7, pages 665-673.
Crossref
Crossref
Elyse Walk & Scott Weed. (2011) Recently Identified Biomarkers That Promote Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma. Cancers 3:1, pages 747-772.
Crossref
Crossref
Wei Liu, Yibing Fu, Shangchen Xu, Feng Ding, Guangyu Zhao, Kang Zhang, Chigang Du, Bo Pang & Qi Pang. (2011) c-Met expression is associated with time to recurrence in patients with glioblastoma multiforme. Journal of Clinical Neuroscience 18:1, pages 119-121.
Crossref
Crossref
Chul-Ho Kim, Yoon Woo Koh, Jae Ho Han, Jae Wook Kim, Jin Seok Lee, Seung Jae Baek, Hye Sook Hwang & Eun Chang Choi. (2010) c-Met expression as an indicator of survival outcome in patients with oral tongue carcinoma. Head & Neck 32:12, pages 1655-1664.
Crossref
Crossref
Iwona Gisterek, Rafał Matkowski, Elzbieta Suder, Agnieszka Hałoń, Jolanta Szelachowska, Ewelina Łata, Aleksandra Łacko, Przemysław Biecek & Jan Kornafel. (2010) Correlation between hepatocyte growth factor receptor and vascular endothelial growth factor-A in breast carcinoma.. Folia Histochemica et Cytobiologica 48:1.
Crossref
Crossref
Michael Montag, Gerhard Dyckhoff, Jennifer Lohr, Burkhard M. Helmke, Eva Herrmann, Peter K. Plinkert & Christel Herold-Mende. (2009) Angiogenic growth factors in tissue homogenates of HNSCC: expression pattern, prognostic relevance, and interrelationships. Cancer Science 100:7, pages 1210-1218.
Crossref
Crossref
Lynn M. Knowles, Laura P. Stabile, Ann Marie Egloff, Mary E. Rothstein, Sufi M. Thomas, Christopher T. Gubish, Edwina C. Lerner, Raja R. Seethala, Shinsuke Suzuki, Kelly M. Quesnelle, Sarah Morgan, Robert L. Ferris, Jennifer R. Grandis & Jill M. Siegfried. (2009) HGF and c-Met Participate in Paracrine Tumorigenic Pathways in Head and Neck Squamous Cell Cancer. Clinical Cancer Research 15:11, pages 3740-3750.
Crossref
Crossref
Angela Coxon, Karen Rex, Susanne Meyer, Jianling Sun, Jilin Sun, Qing Chen, Robert Radinsky, Richard Kendall & Teresa L. Burgess. (2009) Soluble c-Met receptors inhibit phosphorylation of c-Met and growth of hepatocyte growth factor: c-Met–dependent tumors in animal models. Molecular Cancer Therapeutics 8:5, pages 1119-1125.
Crossref
Crossref
Tanguy Y. Seiwert, Ramasamy Jagadeeswaran, Leonardo Faoro, Varalakshmi Janamanchi, Vidya Nallasura, Mohamed El Dinali, Soheil Yala, Rajani Kanteti, Ezra E.W. Cohen, Mark W. Lingen, Leslie Martin, Soundararajan Krishnaswamy, Andres Klein-Szanto, James G. Christensen, Everett E. Vokes & Ravi Salgia. (2009) The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma. Cancer Research 69:7, pages 3021-3031.
Crossref
Crossref
Ali Razfar & Jennifer R. Grandis. 2010. Oral Cancer Metastasis. Oral Cancer Metastasis
185
196
.
Amit Gupta, Pierre I. Karakiewicz, Claus G. Roehrborn, Yair Lotan, Alexandre R. Zlotta & Shahrokh F. Shariat. (2008) Predictive Value of Plasma Hepatocyte Growth Factor/Scatter Factor Levels in Patients with Clinically Localized Prostate Cancer. Clinical Cancer Research 14:22, pages 7385-7390.
Crossref
Crossref
Young Chang Lim, Hun Yi Park, Hye Sook Hwang, Sung Un Kang, Jung Hee Pyun, Mi Hye Lee, Eun Chang Choi & Chul-Ho Kim. (2008) (−)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells. Cancer Letters 271:1, pages 140-152.
Crossref
Crossref
Eirik Sundlisæter, Aly Dicko, Per Øystein Sakariassen, Karl Sondenaa, Per Øyvind Enger & Rolf Bjerkvig. (2007) Lymphangiogenesis in colorectal cancer—Prognostic and therapeutic aspects. International Journal of Cancer 121:7, pages 1401-1409.
Crossref
Crossref
Chul-Ho Kim, JangHee Kim, Hison Kahng & Eun Chang Choi. (2007) Change of E-Cadherin by Hepatocyte Growth Factor and Effects on the Prognosis of Hypopharyngeal Carcinoma. Annals of Surgical Oncology 14:5, pages 1565-1574.
Crossref
Crossref